Kaken Pharmaceutical Co., Ltd.
KKPCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $157 | $154 | $154 | $160 |
| - Cash | $45 | $43 | $54 | $63 |
| + Debt | $4 | $4 | $4 | $4 |
| Enterprise Value | $116 | $114 | $104 | $100 |
| Revenue | $0 | $19 | $18 | $25 |
| % Growth | -99.3% | 4.6% | -26.7% | – |
| Gross Profit | $0 | $10 | $9 | $15 |
| % Margin | 57.1% | 52.3% | 51.8% | 61.3% |
| EBITDA | $0 | $0 | -$4 | $7 |
| % Margin | 8.9% | 0% | -20.8% | 26.5% |
| Net Income | $0 | $0 | -$5 | $5 |
| % Margin | 3.5% | 1.4% | -29% | 19.9% |
| EPS Diluted | 0.13 | 7.12 | -133.99 | 129.09 |
| % Growth | -98.2% | 105.3% | -203.8% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |